Report cover image

In Vitro Diagnostics Business Outlook, Volume 3, Issue 4 - Blood Screening

Publisher Kalorama Information
Published Sep 20, 2024
Length 35 Pages
SKU # KLI19184312

Description

In Vitro Diagnostics Business Outlook, Volume 3, Issue 4 - Blood Screening


ISSUE 4 OF 6 - In Vitro Diagnostics Business Outlook, Volume 3, Issue 4 - Blood Screening

(price includes 6 issues published every two months)In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.

In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:

Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
  • A comprehensive view of the IVD market with test categories covered and company briefs
  • M&A activities, selected partnerships & collaborations, partnership deals, and more
  • Industry & region watch to help tailor strategies
  • Analysis of news and events and reporting on news not easily available

Table of Contents

35 Pages
MARKET ANALYSIS: FOCUS ON BLOOD SCREENING DIAGNOSTICS
OVERVIEW OF BLOOD SCREENING
MARKET OUTLOOK
Figure: Blood Screening Market, 2019-2029 ($ billion)
Figure: Blood Screening Sales, by Test Method, 2024 and 2029 ($ billion) (Immunoassay Screen, NAT Screens)
Figure: Blood Donation Screening Market Distribution, by Analyte, 2024 (%) (Hepatitis, HIV, Other)
REGIONAL MARKET
Table: Estimated Blood Donations, by WHO Region, 2018
Figure: Whole Blood Donations per 1000 Population, 2018
Table: Blood Screening Market Distribution, by Global Region, 2024 (%) (Asia Pacific, Europe, North America, RoW)
Figure: Blood Screening Market Distribution of Sales, by Global Region (%) (Asia Pacific, Europe, North America, RoW)
Segment Activity by Region
Immunoassays
Figure: Market Summary: Immunoassay Blood Screening Market, Distribution of Sales, by Region, 2024 (%) (Asia Pacific, Europe, North America, RoW)
Molecular
Figure: Market Summary: NAT Blood Screening Market, Distribution of Sales by Region (North America, Europe, Asia Pacific, RoW), 2024
TOP COMPANY BRIEFS
Roche
Grifols
Abbott
EXECUTIVE NEWS BRIEFING
BRIEFS
Trinity Biotech Engages New CCO
BillionToOne Closes Financing Deal
OraSure Technologies Elects New Board Member
Viome Life Sciences Secures $25 Million in Financing
Syantra Raises $3.6 Million in A-1 Round Financing
FINANCIAL HIGHLIGHTS: DEXCOM AND EXACT SCIENCES
Dexcom Revenues Increase 15% (+$133 million) in Q2 2024
Figure: Dexcom Revenue Mix, by Product Segment, Q2 2023 and Q2 2024
Figure: Dexcom Revenue Mix by Product Segment, By Quarter 2022 – Q2 2024
Table: Dexcom Geographic Revenues, by Region, Q2 2023 and Q2 2024 ($ million)
Exact Sciences Reports it “Tested a Record Number of Cancer Patients with Oncotype DX”
Figure: Exact Sciences Revenue Mix, by Product Segment, Q2 2023 vs Q2 2024 ($ million)
Figure: Exact Sciences Revenue Mix, by Product Segment, by Quarter 2022-Q2 2024 ($ million)
DIAGNOSTIC MARKET MERGERS, ACQUISITIONS AND PARTNERSHIP DEALS
PARTNERSHIPS AND COLLABORATIONS
MERGERS AND ACQUISITIONS
Table: Selected Diagnostic Market Mergers and Acquisitions Deals
REGION WATCH
Figure: South Korea GDP, GDP (PPP), and Health Spending, CAGR 2005-2010, 2010-2015, 2015-2020 and 2020-2023 (%)
Figure: South Korea Medical Tourism Visits Reported, 2009-2023 (# of patients)
Figure: South Korea Old-Age Dependency Ratio and Aging Index, 1980-2065
BROAD-BASED COMPANY ANNOUNCEMENTS
ANNOUNCEMENTS
Foundation Medicine Gets the Nod for Its Companion Diagnostics
QuidelOrtho Proud to Announce Clearance for VITROS Syphilis Assay
AliveDx Receives IVDR-CE Mark for Multiplexed Assay
T2 Biosystems Scores FDA Pediatric Clearance
ID-FISH Technology Announces FDA Nod for its Lyme ImmunoBlot

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us